Home > News > Starpharma: A Buying Opportunity?
June 22nd, 2006
Starpharma: A Buying Opportunity?
Abstract:
Jack Uldrich: Yesterday, shares of Starpharma’s ADR (Advance Deposit Receipts) plummetted 25 percent on no discernible news. I was surprised and disappointed by the drop — especially because I had just bought more shares the other day when the stock (Nasdaq: SPHRY) was trading at $3.50 and I didn’t think it could go any lower.
Source:
NanoNovus
Related Links |
Related News Press |
Investments/IPO's/Splits
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 20th, 2018
Nanometrics to Present at the 30th Annual ROTH Conference February 27th, 2018
180 Degree Capital Corp. Reports Net Asset Value per Share of $2.60 as of December 31, 2017; A Decrease of 3.0% From Prior Quarter and an Increase of 11.1% From December 31, 2016 February 27th, 2018
Announcements
Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells April 20th, 2018
New qubit now works without breaks: A universal design for superconducting qubits has been created April 19th, 2018
Observing biological nanotransporters: Chemistry April 19th, 2018
Salt boosts creation of 2-D materials: Rice University scientists show how salt lowers reaction temperatures to make novel materials April 18th, 2018
Financial Reports
Nanometrics to Announce First Quarter Financial Results on May 1, 2018 April 10th, 2018
180 Degree Capital Corp. Reports Net Asset Value per Share of $2.60 as of December 31, 2017; A Decrease of 3.0% From Prior Quarter and an Increase of 11.1% From December 31, 2016 February 27th, 2018
Arrowhead Pharmaceuticals to Webcast Fiscal 2018 First Quarter Results February 3rd, 2018
Nanometrics Announces Preliminary Results for the Third Quarter of 2017: Quarterly Results Impacted by Delays in Revenue Recognition on Multiple Systems into Japan October 12th, 2017
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |